IL80182A - Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance - Google Patents

Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance

Info

Publication number
IL80182A
IL80182A IL80182A IL8018286A IL80182A IL 80182 A IL80182 A IL 80182A IL 80182 A IL80182 A IL 80182A IL 8018286 A IL8018286 A IL 8018286A IL 80182 A IL80182 A IL 80182A
Authority
IL
Israel
Prior art keywords
darodipine
isradipine
active substance
controlled release
pharmaceutical formulations
Prior art date
Application number
IL80182A
Other versions
IL80182A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL80182A0 publication Critical patent/IL80182A0/en
Publication of IL80182A publication Critical patent/IL80182A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL80182A 1985-10-01 1986-09-29 Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance IL80182A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL80182A0 IL80182A0 (en) 1986-12-31
IL80182A true IL80182A (en) 1991-01-31

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
IL80182A IL80182A (en) 1985-10-01 1986-09-29 Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance

Country Status (20)

Country Link
KR (1) KR920008817B1 (en)
AT (1) AT402257B (en)
BE (1) BE905516A (en)
CA (1) CA1298784C (en)
CH (1) CH669524A5 (en)
DE (1) DE3632201C2 (en)
DK (1) DK170016B1 (en)
ES (1) ES2002508A6 (en)
FR (1) FR2589732B1 (en)
GR (1) GR862457B (en)
HK (1) HK392A (en)
HU (1) HU197201B (en)
IE (1) IE59589B1 (en)
IL (1) IL80182A (en)
LU (1) LU86615A1 (en)
NL (1) NL194822C (en)
NZ (1) NZ217732A (en)
PT (1) PT83456B (en)
SE (1) SE503222C2 (en)
SG (1) SG103391G (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
EP1383496B1 (en) * 2001-02-20 2008-10-01 Dinan, Timothy Gerard Treatment of fibromyalgia using pindolol
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
DD145004A3 (en) * 1978-09-25 1980-11-19 Reinhard Huettenrauch METHOD FOR PRODUCING SOLID A NOMENCLATES
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (en) * 1980-05-21 1985-12-09 塩野義製薬株式会社 sustained release formulation
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
KR850700212A (en) * 1984-03-21 1985-12-26 죠지 드모트 Sustained Release Pharmaceutical Wexel
JPS6124516A (en) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd Long active tablet

Also Published As

Publication number Publication date
SE8604112L (en) 1987-04-02
HU197201B (en) 1989-03-28
ATA260486A (en) 1996-08-15
PT83456B (en) 1989-05-12
HUT44701A (en) 1988-04-28
IL80182A0 (en) 1986-12-31
DE3632201C2 (en) 1997-05-07
KR870003777A (en) 1987-05-04
GR862457B (en) 1987-01-29
BE905516A (en) 1987-03-30
PT83456A (en) 1986-10-01
NZ217732A (en) 1990-07-26
NL194822B (en) 2002-12-02
DK464686D0 (en) 1986-09-29
CH669524A5 (en) 1989-03-31
KR920008817B1 (en) 1992-10-09
CA1298784C (en) 1992-04-14
AT402257B (en) 1997-03-25
SE503222C2 (en) 1996-04-22
DE3632201A1 (en) 1987-04-02
IE59589B1 (en) 1994-03-09
DK464686A (en) 1987-04-02
NL194822C (en) 2003-04-03
FR2589732A1 (en) 1987-05-15
ES2002508A6 (en) 1988-08-16
DK170016B1 (en) 1995-05-01
SG103391G (en) 1992-01-17
SE8604112D0 (en) 1986-09-29
IE862565L (en) 1987-04-01
HK392A (en) 1992-01-10
FR2589732B1 (en) 1989-07-13
LU86615A1 (en) 1987-04-02
NL8602370A (en) 1987-05-04

Similar Documents

Publication Publication Date Title
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
GB2211413B (en) Pharmaceutical formulations comprising microcapsules
GB8502974D0 (en) Sustained release of active substance
EP0194838A3 (en) Controlled-release pharmaceutical formulation
GB8504099D0 (en) Physiologically active substances
ZA90946B (en) Medicament containing dihydrolipoic acid as active substance
GB8630870D0 (en) Active support substance
GB2187643B (en) Method for the preparation of tablets slowly releasing the active principle
EP0440809A4 (en) Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
IL74049A0 (en) Controlled release liquid dosage pharmaceutical formulations
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
IL79163A0 (en) 1,8-bridged 4-quinolone-3-carboxylic acids,their preparation,medicaments containing them and their use for the preparation of medicaments
HUT43918A (en) Herbicides comprising derivatives of 3-/substituted-oxy/-2-benzoyl-cyclohex-2-enone as active substance
PH16618A (en) 7beta-aminothiadiazolyl-acetamido-3-cepem-4-carboxylic acid compounds,pharmaceutical preparation containing such compounds and the use of the latter
GB2190287B (en) Controlled release ketoprofen pharmaceutical formulation
IL80182A (en) Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance
HUT41757A (en) Process for producing pharmaceutical compositions containing e-desmethyl-mevalonic acid derivatives and process for producing the active agents
HU895680D0 (en) Insecticides containing as active substance derivatives of chrisanthemate
PH23398A (en) Indenopyrimidine derivatives and pharmaceutical formulation containing the same
HUT42679A (en) Insecticidal and acaricidal compositions comprising alkanoyl-anilide derivatives as active substance and process for preparing the active substances
HUT43044A (en) Herbicides comprising 1-aryl-pyrazole derivatives as active substance and process for preparing the active substances
ZA867507B (en) Pharmaceutical formulations with controlled release of the active substance
HUT41401A (en) Acaricidal compositions comprising thiadiazole derivatives as active substance and process for preparing the active substances
AU6322686A (en) Pharmaceutical formulations with controlled release of the active substance
ZA875937B (en) Pharmaceutical formulations comprising microcapsules

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
EXP Patent expired